Skip to content

A Study on the Development of a Predictive Model for Postoperative Recurrence of Medullary Thyroid Carcinoma Based on Ultrasound Radiomic Features

A Study on the Development of a Predictive Model for Postoperative Recurrence of Medullary Thyroid Carcinoma Based on Ultrasound Radiomic Features

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600127599
Enrollment
Unknown
Registered
2026-07-02
Start date
2026-07-20
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medullary thyroid cancer

Interventions

Thyroid medullary cancer has not recurred after surgery group:None
Postoperative recurrence of medullary thyroid carcinoma group:None

Sponsors

The First Hospital of Jiaxing
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. No history of thyroid surgery; 2. Preoperative ultrasound examination at the hospital; 3. Underwent thyroid surgery in the hospital, and postoperative pathology confirmed MTC; 4. Complete postoperative follow-up data, with follow-up time of 2 years or more.

Exclusion criteria

Exclusion criteria: 1. Incomplete clinical data and preoperative ultrasound imaging data; 2. Merge with other primary malignant tumors.

Design outcomes

Primary

MeasureTime frame
Postoperative recurrence of MTC;

Secondary

MeasureTime frame
Model predictive performance and clinical value (AUC, accuracy, sensitivity, specificity, calibration curve) DCA? Column chart);Radiomics Score (Rad Score);Clinical and pathological features (including preoperative Ctn, lesion size, number of lesions, membrane invasion, T/N/TNM staging, ultrasound boundary, ultrasound suggestive lymph node metastasis, AC;

Countries

China

Contacts

Public ContactCong Li

The First Hospital of Jiaxing

Wnlicong@126.com+86 573 8251 9663

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026